These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 10415244)
1. MR mammography: influence of menstrual cycle on the dynamic contrast enhancement of fibrocystic disease. Rieber A; Nüssle K; Merkle E; Kreienberg R; Tomczak R; Brambs HJ Eur Radiol; 1999; 9(6):1107-12. PubMed ID: 10415244 [TBL] [Abstract][Full Text] [Related]
2. [MR-imaging of the breast at 0.5 Tesla: menstrual-cycle dependency of parenchymal contrast enhancement in healthy volunteers with oral contraceptive use?]. Lorenzen J; Welger J; Lisboa BW; Krupski G; Adam G Rofo; 2003 Apr; 175(4):502-6. PubMed ID: 12677505 [TBL] [Abstract][Full Text] [Related]
3. False-positive results in dynamic MR mammography. Causes, frequency, and methods to avoid. Kaiser WA Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):539-55. PubMed ID: 7489307 [TBL] [Abstract][Full Text] [Related]
4. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging. Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584 [TBL] [Abstract][Full Text] [Related]
5. MR imaging of the breast with Gd-DTPA enhancement: comparison with mammography and ultrasonography. Hachiya J; Seki T; Okada M; Nitatori T; Korenaga T; Furuya Y Radiat Med; 1991; 9(6):232-40. PubMed ID: 1668410 [TBL] [Abstract][Full Text] [Related]
6. MRI of breast cancer: influence of chemotherapy on sensitivity. Rieber A; Zeitler H; Rosenthal H; Görich J; Kreienberg R; Brambs HJ; Tomczak R Br J Radiol; 1997 May; 70(833):452-8. PubMed ID: 9227225 [TBL] [Abstract][Full Text] [Related]
7. [Contrast medium assisted dynamic MR-mammography after diagnostic and therapeutic interventions on the breast]. Fischer U; Vosshenrich R; Kopka L; Kahlen O; Grabbe E Bildgebung; 1996 Jun; 63(2):94-100. PubMed ID: 8756151 [TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of preoperative contrast-enhanced MR imaging of the breast]. Winnekendonk G; Krug B; Warm M; Göhring UJ; Mallmann P; Lackner K Rofo; 2004 May; 176(5):688-93. PubMed ID: 15122467 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI. Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197 [TBL] [Abstract][Full Text] [Related]
10. Differentiating benign and malignant breast lesions with T2*-weighted first pass perfusion imaging. Kvistad KA; Lundgren S; Fjøsne HE; Smenes E; Smethurst HB; Haraldseth O Acta Radiol; 1999 Jan; 40(1):45-51. PubMed ID: 9973902 [TBL] [Abstract][Full Text] [Related]
11. MR imaging of the breast using gadolinium-DTPA. Heywang SH; Hahn D; Schmidt H; Krischke I; Eiermann W; Bassermann R; Lissner J J Comput Assist Tomogr; 1986; 10(2):199-204. PubMed ID: 3950145 [TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced magnetic resonance imaging of the breast combined with pharmacokinetic analysis of gadolinium-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma. Mussurakis S; Buckley DL; Bowsley SJ; Carleton PJ; Fox JN; Turnbull LW; Horsman A Invest Radiol; 1995 Nov; 30(11):650-62. PubMed ID: 8557506 [TBL] [Abstract][Full Text] [Related]
13. Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue. Delille JP; Slanetz PJ; Yeh ED; Kopans DB; Garrido L Breast J; 2005; 11(4):236-41. PubMed ID: 15982388 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions. Boné B; Péntek Z; Perbeck L; Veress B Acta Radiol; 1997 Jul; 38(4 Pt 1):489-96. PubMed ID: 9240665 [TBL] [Abstract][Full Text] [Related]
15. Effect of the menstrual cycle on background parenchymal enhancement in breast MR imaging. Kajihara M; Goto M; Hirayama Y; Okunishi S; Kaoku S; Konishi E; Shinkura N Magn Reson Med Sci; 2013 Mar; 12(1):39-45. PubMed ID: 23474960 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging. Nishiura M; Yasuhiro T; Murase K Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496 [TBL] [Abstract][Full Text] [Related]
17. Value of MR mammography in the detection and exclusion of recurrent breast carcinoma. Rieber A; Merkle E; Zeitler H; Görich J; Kreienberg R; Brambs HJ; Tomczak R J Comput Assist Tomogr; 1997; 21(5):780-4. PubMed ID: 9294575 [TBL] [Abstract][Full Text] [Related]
18. [Dynamic contrast medium studies with flash sequences in nuclear magnetic resonance tomography of the breast]. Heywang SH; Hilbertz T; Pruss E; Wolf A; Permanetter W; Eiermann W; Lissner J Digitale Bilddiagn; 1988 Mar; 8(1):7-13. PubMed ID: 3383539 [TBL] [Abstract][Full Text] [Related]
19. [Magnetic resonance mammography--even today a routine procedure]. Reif E; Möller TB; Bach M Wien Med Wochenschr; 1994; 144(16):392-8. PubMed ID: 7856213 [TBL] [Abstract][Full Text] [Related]
20. MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. Van Goethem M; Schelfout K; Dijckmans L; Van Der Auwera JC; Weyler J; Verslegers I; Biltjes I; De Schepper A Eur Radiol; 2004 May; 14(5):809-16. PubMed ID: 14615904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]